GlassScriptPhysician profile
Linda Gordon
NPI 1447282637
$778.73
in general payments reported to CMS, 2019-2025
16 companies · $287 in 2025
The $287 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.64 · 2022: $90.65 · 2023: $140 · 2024: $189 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $204.88 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $175.63 | 2019-2025 | Bexsero, Pediarix, Penmenvy |
| Pfizer INC. | $53.70 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $53.23 | 2022-2025 | Enflonsia, Proquad, Gardasil 9 |
| Ironshore Pharmaceuticals INC. | $49.45 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $39.00 | 2025 | Qelbree |
| Sanofi Pasteur INC. | $38.49 | 2024-2025 | |
| Pharming Healthcare, INC. | $26.93 | 2023 | Ruconest |
| Mckesson Medical-Surgical, INC. | $25.43 | 2025 | |
| Sanofi-Aventis U.S. LLC | $21.06 | 2024 | |
| Cranial Technologies, INC | $19.21 | 2019 | |
| Phadia US INC. | $18.89 | 2024 | Immunocap |
| Verrica Pharmaceuticals INC. | $16.66 | 2024 | Ycanth |
| Alk-Abello, INC | $15.68 | 2023 | Odactra, Grastek, Ragwitek |
| Seqirus USA INC | $13.50 | 2025 | Flucelvax |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivaquant INC, Dba Rhythm Express | $6.99 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.